A detailed history of Schroder Investment Management Group transactions in Boston Scientific Corp stock. As of the latest transaction made, Schroder Investment Management Group holds 6,201,057 shares of BSX stock, worth $552 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
6,201,057
Previous 4,362,810 42.13%
Holding current value
$552 Million
Previous $336 Million 54.67%
% of portfolio
0.55%
Previous 0.38%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $134 Million - $154 Million
1,838,247 Added 42.13%
6,201,057 $520 Million
Q2 2024

Aug 12, 2024

BUY
$67.33 - $77.71 $39.2 Million - $45.3 Million
582,633 Added 15.41%
4,362,810 $336 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $45.1 Million - $53.8 Million
783,818 Added 26.16%
3,780,177 $259 Million
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $4.89 Million - $5.81 Million
100,448 Added 3.47%
2,996,359 $173 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $16.5 Million - $18 Million
328,361 Added 12.79%
2,895,911 $153 Million
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $23.6 Million - $26 Million
475,071 Added 22.7%
2,567,550 $139 Million
Q1 2023

May 11, 2023

SELL
$45.09 - $50.03 $2.09 Million - $2.32 Million
-46,441 Reduced 2.17%
2,092,479 $105 Million
Q4 2022

Feb 10, 2023

BUY
$39.56 - $47.22 $7.8 Million - $9.31 Million
197,171 Added 10.15%
2,138,920 $99 Million
Q3 2022

Nov 10, 2022

BUY
$36.71 - $109.66 $46.5 Million - $139 Million
1,265,439 Added 187.11%
1,941,749 $75.2 Million
Q2 2022

Aug 11, 2022

BUY
$35.24 - $47.1 $3.78 Million - $5.06 Million
107,371 Added 18.87%
676,310 $25.2 Million
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $835,055 - $920,806
-20,417 Reduced 3.46%
568,939 $25.4 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $2.21 Million - $2.61 Million
58,142 Added 10.95%
589,356 $25 Million
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $1.83 Million - $2.03 Million
44,276 Added 9.09%
531,214 $23 Million
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $2.36 Million - $2.71 Million
61,265 Added 14.39%
486,938 $20.8 Million
Q1 2021

May 17, 2021

BUY
$35.27 - $39.67 $1.42 Million - $1.59 Million
40,140 Added 10.41%
425,673 $16.5 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $15.1 Million - $19.1 Million
-454,618 Reduced 54.11%
385,533 $13.9 Million
Q3 2020

Nov 13, 2020

BUY
$34.44 - $42.23 $4.21 Million - $5.16 Million
122,273 Added 17.03%
840,151 $32.3 Million
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $2.89 Million - $3.75 Million
95,851 Added 15.41%
717,878 $25.2 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $2.23 Million - $3.95 Million
-86,523 Reduced 12.21%
622,027 $20.5 Million
Q4 2019

Feb 11, 2020

BUY
$37.87 - $45.37 $2.44 Million - $2.92 Million
64,356 Added 9.99%
708,550 $32 Million
Q3 2019

Nov 12, 2019

BUY
$40.31 - $43.45 $2.88 Million - $3.1 Million
71,372 Added 12.46%
644,194 $26 Million
Q2 2019

Aug 08, 2019

BUY
$34.91 - $42.98 $7.11 Million - $8.75 Million
203,647 Added 55.16%
572,822 $24.6 Million
Q1 2019

May 14, 2019

BUY
$32.91 - $40.75 $11.6 Million - $14.3 Million
352,056 Added 2056.52%
369,175 $14.2 Million
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $114,037 - $140,309
3,594 Added 26.57%
17,119 $605,000
Q3 2018

Nov 13, 2018

BUY
$32.83 - $38.63 $4,826 - $5,678
147 Added 1.1%
13,525 $521,000
Q2 2018

Aug 13, 2018

SELL
$26.84 - $34.32 $4.12 Million - $5.27 Million
-153,544 Reduced 91.99%
13,378 $435,000
Q4 2017

Feb 09, 2018

SELL
$24.79 - $29.8 $2.14 Million - $2.58 Million
-86,499 Reduced 34.13%
166,922 $4.14 Million
Q3 2017

Nov 09, 2017

BUY
$26.26 - $29.17 $6.65 Million - $7.39 Million
253,421
253,421 $7.28 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.